Mexico’s government continues to cook up nationwide distributor plans



Mexico’s President Andrés Manuel López Obrador this week announced plans to create a state-owned distributor of drugs, vaccines, and medical equipment. He said that the company will reach even the most remote areas to help solve the undersupply of health products in the country.

López Obrador first mentioned the project last year, and since then has proposed state-owned firm Biológicos y Reactivos de México (Birmex) and the Mexican Institute of Social Security (IMSS) for the task.

Reference:

Recent news
Cuba’s state-run BioCubaFarma and UK’s SG Innovations this week announced the creation of biopharmaceutical joint venture (JV) Biofarma Innovations, which will be based in the United Kingdom.
Hutchison China MediTech Ltd (Chi-Med; Nasdaq/AIM: HCM) released its H1 2020 financial report, with updates on key clinical and commercial developments. Group revenues reached USD 107 million, up 4.5% year-on-year(YOY).
China-based biotech BeiGene Ltd (Nasdaq.BGNE; HKEX.06160) released financial results for Q2 2020.
Denmark-based firm Novo Nordisk released H1 2020 financials, shrugging off COVID-19 disruptions with 7% year-on-year (YOY) global sales growth (in constant exchange rate terms, as per all growth figures) to DKK 63.9 billion (USD 10.15 billion).
US-based biotech Biogen Inc., (Nasdaq.BIIB) committed to a deal worth over USD 2 billion to add an innovative Parkinson’s disease therapy to its pipeline for US and China development.
Bolivia’s Ministry of Health (MoH) this week announced it is taking measures to ensure the free provision of treatments used to treat COVID-19.
Analytics Snapshot


Analytics Snapshot